BH-009
- Generic Name
- BH-009
A Study of BH009 in Head and Neck Squamous Cell Carcinoma and Ovarian Cancer
- First Posted Date
- 2024-01-31
- Last Posted Date
- 2024-02-02
- Lead Sponsor
- Zhuhai Beihai Biotech Co., Ltd
- Target Recruit Count
- 24
- Registration Number
- NCT06232863
- Locations
- 🇨🇳
The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
🇨🇳The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China
🇨🇳Hunan Cancer Hospital, Changsha, Hunan, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath